Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List RETAPAMULIN

RETAPAMULIN synthesis

3synthesis methods
Retapamulin, also known as SB-275833, is a newer topical agent of pleuromutilin class approved by the Food and Drug Administration for treatment of impetigo in children. It has been demonstrated to have low potential for the development of antibacterial resistance and a high degree of potency against poly drug resistant Gram-positive bacteria found in skin infections including Staphylococcus aureus strains. The drug is safe owing to low systemic absorption and has only minimal side-effect of local irritation at the site of application.
Synthetic Routes
  • ROUTE 1
  • 202112070531310998.jpg

    Breen, Gary Francis; Forth, Michael Anthony; Kopelman, Susan Shumei Hu; Muller, Francis Xavier; Sanderson, Francis Dominic. Process for preparation of mutilin derivatives and their salts as antibacterial agents. Assignee Glaxo Group Limited, UK. WO 2005023257. (2005).

  • ROUTE 2
  • 202112079287776712.jpg

    Cheng, Gang; Huang, Shenghong. Method for preparation and purification of Retapamulin. CN 103450182. (2013).

  • ROUTE 3
  • 202112077187118966.jpg

    Wang, Fan; Zhan, Xiao; Li, Hongqiang; Yang, Yujin. A novel method for preparing retapamulin. Assignee Chongqing Huapont Shengkai Pharmaceutical Co., Ltd., Peop. Rep. China. CN 107324998. (2017).

  • ROUTE 4
  • 202112074907325281.jpg

    Huang, Huoming; Hao, Qun; Li, Hongyan; Zhou, Weicheng. Synthesis of retapamulin. Zhongguo Yiyao Gongye Zazhi. Volume 45. Issue 12. Pages 1101-1103. 2014.

  • ROUTE 5
  • 202112070490236837.jpg

    Feng, Rujie; Shi, Yalin; Wu, Yiwu; Bei, Rongbing; Chen, Hailong. A method for synthesis of retapamulin. Assignee Shantou Special Economic Zone Tuobin Pharmaceutical Factory, Peop. Rep. China. CN 105037348. (2015).

  • ROUTE 6
  • 202112071958042026.jpg

    Pandey, Bipin; Dave, Mayank G.; Patel, Sunil I.; Gandhi, Jinal. Improved process for the preparation of pleuromutilin derivative. Assignee Cadila Healthcare Limited, India. IN 2012MU01278. (2014).

  • ROUTE 7
  • 202112079825161810.jpg

    Xiao, Li; Zhao, Chuanmeng; Zhang, Chuntao; Ni, Guowei; Zhang, Fuli. Synthesis of retapamulin. Zhongguo Yiyao Gongye Zazhi. Volume 43. Issue 8. Pages 641-643. 2012.

  • ROUTE 8
  • 202112072512313891.jpg

    Liu, Yahong; Tang, Youzhi. A method for preparation of Retapamulin. Assignee South China Agricultural University, Peop. Rep. China. CN 102267992. (2011).

  • ROUTE 9
  • 202112074579517574.jpg

    Wang, Li-qiang; Feng, Wen-hua; Zhang, Yue. Process improvement on the synthesis of peuromulin antibiotics retapamulin. Hecheng Huaxue. Volume 19. Issue 4. Pages 554-556. 2011.

  • ROUTE 10
  • 202112077787707309.jpg

    Jaber, Nimer; Hedvati, Lilach; Eyal, Gilboa; Avhar-Maydan, Sharon. Preparation of retapamulin via its pleuromutilin-thiol precursor. Assignee Teva Pharmaceutical Industries Ltd., Israel; Teva Pharmaceuticals USA, Inc. WO 2010056855. (2010).

202112070531310998.jpg

Breen, Gary Francis; Forth, Michael Anthony; Kopelman, Susan Shumei Hu; Muller, Francis Xavier; Sanderson, Francis Dominic. Process for preparation of mutilin derivatives and their salts as antibacterial agents. Assignee Glaxo Group Limited, UK. WO 2005023257. (2005).

8-Azabicyclo[3.2.1]octane-3-thiol, 8-Methyl-, (3-exo)-

848130-83-6
4 suppliers
inquiry

60924-38-1 Synthesis
2-[(Methylsulfonyl)oxy]acetic acid (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester

60924-38-1
51 suppliers
inquiry

-

Yield:224452-66-8 80%

Reaction Conditions:

with triethylamine in 4-methyl-2-pentanone at 20 - 40; for 2 - 24 h;Product distribution / selectivity;

Steps:

17; 18 Preparation of Retapamulin
Example 17 Preparation of Retapamulin A 3 neck-flask (100 ml) was charged with tropine thiol (5-10 mmol), a solvent (5 vol) and a base (2.5 eq). The solvents and bases are listed in Table 1 below. Pleuromutilin mesylate (11 mmol) was then added to the flask in portions. The resulting combination was stirred at room temperature to 40° C. for 2-24 hours until full conversion to Retapamulin was achieved. Example 18Preparation of RetapamulinIn a 500 ml round bottom flask, tropine thiol (15 g), methyl isobutyl ketone (8 vol) and triethylamine (2.4 eq.) were charged. The mixture was stirred at 40° C. for 15 minutes. Pleuromutilin mesylate (1 eq.) was added. The mixture was stirred as a slurry at 40° C. for 12 hours. Water (7 vol) was added and the pH was adjusted to 8.5 using 4N HCl. The phases were separated. Water (7 vol) was added to the organic phase, the pH was adjusted to 8.2, and the phases separated again. The organic phase was extracted with water (7 vol) and the pH was adjusted to 1.5. After separation, the pH of the aqueous phase was adjusted to 12.5 with 4N NaOH. The mixture was stirred at room temperature for 20 hours. The product was vacuum filtered and washed with water. The collected crystals were dried in a 55° C. vacuum oven to yield 80% Retapamulin at 99.8% purity as determined by HPLC.

References:

Hedvati, Lilach;Gilboa, Eyal;Avhar-Maydan, Sharon;Shachan-Tov, Sharona US2009/149655, 2009, A1 Location in patent:Page/Page column 3; 5; 6

FullText

RETAPAMULIN Related Search: